Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nigral volumetric and microstructural measures in individuals with scans without evidence of dopaminergic deficit

medRxiv(2022)10.1101/2022.10.26.22281257Source: DataRank Database

Nigral volumetric and microstructural measures in individuals with scans without evidence of dopaminergic deficit is a research paper published in medRxiv (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (23)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Kristy Hwang ORCID,Xiaoping Hu ORCID,Daniel E. Huddleston ORCID,Jason Langley ORCID

Live enrichment

PubMed:21097893 OpenAlex:https://openalex.org/W4307628825

National Institutes of Health

Grant: 1K23NS105944-01A1

MRI Signatures of Neuromelanin and Iron Pathology in Parkinsonism

National Institutes of Health

Grant: 1I01RX002967-01A2

Partnered Dance Aerobic Exercise as a neuroprotective, motor and cognitive intervention in Parkinson's disease

National Institutes of Health

Grant: 1U19AG071754-01

North American Prodromal Synucleinopathy Consortium for RBD, Stage 2 (NAPS2)

greenLicense: cc-by-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2022/10/30/2022.10.26.22281257.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.10.26.22281257

repositoryhttps://doi.org/10.1101/2022.10.26.22281257

https://doi.org/10.3389/fnins.2022.1048945

Fields of Study

Parkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsAdvanced Neuroimaging Techniques and Applications03 medical and health sciences0302 clinical medicine

Keywords

Pars compactaSubstantia nigraNeuromelaninDopaminergicParkinson's diseaseParkinsonismMedicineNeuroscienceDopamineInternal medicinePsychologyDiseasefree waterParkinson’s diseasesubstantia nigra pars compactaNeurosciences. Biological psychiatry. Neuropsychiatryscans without evidence of dopaminergic deficitRC321-571

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Clean water and sanitation